Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 9, 2026
FPA Crescent Fund - Institutional Class gained 1.48% net of fees in Q3 2026 and 10.34% net of fees over the trailing twelve-month period. For the trailing twelve months, the fund captured 61.7% of the MSCI ACWI return of 16.75% while maintaining an average net risk exposure of 64.0%. Net risk exposure ended the quarter at 66.5%, up from 63.3% in Q2 2026, driven by a common stock long exposure of 62.7%, common short exposure of -0.5%, long credit exposure of 1.3%, and other assets of 3.0%. The fund maintained significant dry powder, deploying capital into short-term U.S. Treasuries with yields near 5% and initiating positions in TIPS with real yields above 3%. From a macroeconomic perspective, the managers highlighted opportunities created by the higher interest rate regime in government debt, while noting that corporate credit spreads remain relatively tight versus Treasuries. Management observed that the rapid rise in interest rates is likely to trigger stress somewhere within credit markets, establishing a disciplined posture to deploy capital once dislocations arise. Consequently, the fund trimmed exposures to beneficiaries of the artificial intelligence ecosystem while selectively identifying value in neglected market segments. Portfolio activity reflected selective capital deployment across both domestic and international equities. The managers introduced new positions in healthcare via Boston Scientific and HCA Healthcare, while adding small- and mid-cap holdings including Core & Main, Fluidra, and JBT Marel. Key trailing twelve-month performance contributors included Alphabet, Analog Devices, and Samsung C&T, whereas Prosus, Charter Communications, and Jefferies detracted from returns amid company-specific and cyclical headwinds.
Deploy capital patiently across global asset classes into durable businesses at sensible valuations while maintaining substantial liquidity to capitalize on credit and market dislocations.
The managers intend to remain patient and disciplined, noting that they are currently building positions in several new investments that offer attractive long-term return potential at sensible valuations. They expect to share further details in their upcoming year-end letter while keeping capital ready to exploit emerging credit market stress.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with FPA Crescent Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.